Thermo Fisher Scientific Inc.

Healthcare

NYSE:TMO · New York Stock Exchange

Market Cap $174.50B Beta 0.87 P/E (TTM) 25.5

$469.57 -1.28%

-$6.09 today

52W Low $385.46High $643.99

Vol 0.58M · Avg 2.36M

EPS (TTM)$18.44

Div Yield0.37%

Medical - Diagnostics & Research

Filings

Ground the analysis in primary documents

Pair price history with recent company filings so you can connect market moves to the actual disclosures behind the business.

Price History

Dividend-adjusted closing price

Events

Change

+13.50%

Period High

$638.82

Period Low

$389.23

Latest

$469.67

SEC Filings

Recent regulatory filings

No filings found.

Competitors

Peer companies in the same sector

Health

Merck & Co., Inc.

NYSE:MRK

$296.00B

Novartis AG

NYSE:NVS

$292.70B

AstraZeneca PLC

NYSE:AZN

$278.81B

Novo Nordisk A/S

NYSE:NVO

$196.64B

Amgen Inc.

NASDAQ:AMGN

$190.71B

Abbott Laboratories

NYSE:ABT

$152.86B

Intuitive Surgical, Inc.

NASDAQ:ISRG

$144.58B

Danaher Corporation

NYSE:DHR

$127.55B

Agilent Technologies, Inc.

NYSE:A

$36.44B

IQVIA Holdings Inc.

NYSE:IQV

$29.86B

What is the latest TMO filing?

The latest filing shown is SD dated May 28, 2026.

How many recent filings does TMO have?

Intrinsic Alpha currently shows 20 recent filings for TMO.

Explore More

Continue the stock analysis

Jump to another research area for this company.

OverviewStart with valuation, alerts, peers, and the full company snapshot.DCFAdjust assumptions and compare intrinsic value against the market price.FinancialsReview income statement, balance sheet, and cash flow trends.HealthCheck liquidity, leverage, and balance sheet strength.GrowthCompare historical growth, cash generation, targets, and peers.DividendsInspect dividend history, payout durability, and shareholder returns.ManagementReview leadership context, insider activity, and capital efficiency.